Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20131246 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Rituximab Treatment in Sjogren's Syndrome
Condition: Sjogren's Syndrome
Intervention: Drug: rituximab (anti-CD20)

Indicates status has not been verified in more than two years